Stability and tolerability of high concentrations of intrathecal bupivacaine and opioid mixtures in chronic noncancer pain: an open-label pilot study.
Goucke
C Roger
CR
Department of Pain Management, Sir Charles Gairdner Hospital, Nedlands, Australia. roger.goucke@health.wa.gov.au
Dusci
Leon J
LJ
Van Leeuwen
Shane
S
Fairclough
Denise
D
Ilett
Ken F
KF
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000701:Analgesics, Opioid / Q000008:administration & dosage* / Q000009:adverse effects; D000779:Anesthetics, Local / Q000008:administration & dosage* / Q000009:adverse effects; D002045:Bupivacaine / Q000008:administration & dosage* / Q000009:adverse effects; D002851:Chromatography, High Pressure Liquid; D002908:Chronic Disease; D004355:Drug Stability; D005260:Female; D006801:Humans; D004091:Hydromorphone / Q000008:administration & dosage* / Q000009:adverse effects; D015918:Infusion Pumps, Implantable; D007278:Injections, Spinal; D008297:Male; D008875:Middle Aged; D009020:Morphine / Q000008:administration & dosage* / Q000009:adverse effects; D010146:Pain / Q000188:drug therapy*; D010147:Pain Measurement; D010865:Pilot Projects
D000701:Analgesics, Opioid; D000779:Anesthetics, Local; D009020:Morphine; D004091:Hydromorphone; D002045:Bupivacaine